APA (7th ed.) Citation

DN, F., JA, L., Z, Y., H, I., T, P., R, N., . . . JA, F. (2021). Adjunctive everolimus therapy for tuberous sclerosis complex-associated refractory seizures: Results from the postextension phase of EXIST-3. Epilepsia, 62(12), 3029. https://doi.org/10.1111/epi.17099

Chicago Style (17th ed.) Citation

DN, Franz, et al. "Adjunctive Everolimus Therapy for Tuberous Sclerosis Complex-associated Refractory Seizures: Results from the Postextension Phase of EXIST-3." Epilepsia 62, no. 12 (2021): 3029. https://doi.org/10.1111/epi.17099.

MLA (9th ed.) Citation

DN, Franz, et al. "Adjunctive Everolimus Therapy for Tuberous Sclerosis Complex-associated Refractory Seizures: Results from the Postextension Phase of EXIST-3." Epilepsia, vol. 62, no. 12, 2021, p. 3029, https://doi.org/10.1111/epi.17099.